Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04021524
Other study ID # STUDY00005028
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date September 10, 2018
Est. completion date April 16, 2021

Study information

Verified date December 2021
Source University of Washington
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized trial of benzoyl peroxide soap versus Hibiclens soap for surgical preparation. The objective is to determine whether benzoyl peroxide soap, commonly available in drug stores for over-the-counter acne treatment, is as or more effective than the standard surgical preoperative soap, Hibiclens soap (chlorhexidine gluconate), in reducing loads of Propionibacteria (Propi) on or under the skin of patients prior to shoulder arthroplasty (joint replacement).


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date April 16, 2021
Est. primary completion date May 31, 2019
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 89 Years
Eligibility Inclusion Criteria: - Male subjects - Subjects scheduled for elective shoulder arthroplasty at the University of Washington Medical Center - Subjects between ages 18-89 Exclusion Criteria: - Subjects who self-report very sensitive skin - Subjects who are sensitive to benzoyl peroxide - Subjects who are allergic to chlorhexidine - Subjects who had recent prior use of antibiotics (or expect to use them prior to surgery) - Subjects who had recent use of acne treatment - Subjects who are not fluent in English.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Benzoyl Peroxide 10% Bar
Patients will wash with Benzoyl Peroxide 10% Bar
Chlorhexidine Gluconate
Patients will wash with Chlorhexidine Gluconate

Locations

Country Name City State
United States University of Washington Seattle Washington

Sponsors (1)

Lead Sponsor Collaborator
University of Washington

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Patients With a Positive Propionibacteria Swabs on Day of Surgery After At-Home Washes With Benzoyl Peroxide or Chlorhexidine Gluconate Patients were randomly assigned to use either benzoyl peroxide soap or Hibiclens soap (chlorhexidine gluconate) at home the night before and the morning of surgery. On the day of surgery the patients' skin and incisions were swabbed in the operating room prior to shoulder arthroplasty. Specimens were held for 21 days. Day of Surgery
Primary Number of Quadrants on Culture Plate of Propionibacteria Growth - Specimens Taken Day of Surgery After At-Home Washes With Benzoyl Peroxide or Chlorhexidine Gluconate This outcome measures the load of Propionibacteria on the skin and incision of participants in the operating room prior to shoulder arthroplasty when patients were randomly assigned to use either benzoyl peroxide soap or Hibiclens soap (chlorhexidine gluconate) at home the night before and the morning of surgery. The Propionibacteria load was quantified based on the growth of bacteria on the agar plate using a quadrant system. Quantitative specimen Propionibacteria values (SpCuVs) were assigned as following: "no growth"= 0, "broth only"= 0.1, "one colony only"= 0.1, and 1 quadrant growth = 1, 2 quadrant growth = 2, 3 quadrant growth = 3, and 4 quadrant growth = 4. Samples were taken on the day of surgery and the cultures were held for 21 days. Day of Surgery
See also
  Status Clinical Trial Phase
Completed NCT00211523 - Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne Phase 2
Completed NCT03057821 - Propionibacterium Acnes in Shoulder Arthroplasty N/A
Completed NCT00211497 - Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne Phase 2